We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
-19.67%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$2.74B
AUM Growth
-$52.2M
Cap. Flow
+$616M
Cap. Flow %
22.46%
Top 10 Hldgs %
20.88%
Holding
327
New
27
Increased
203
Reduced
54
Closed
34

Top Buys

Rank Stock Value
1
MYGN icon
Myriad Genetics
MYGN
+$28.8M
2
WW
WW International
WW
+$26.6M
3
WIX icon
WIX.com
WIX
+$21.1M
4
PINC
Premier
PINC
+$20.4M
5
URBN icon
Urban Outfitters
URBN
+$19.1M

Sector Composition

Rank Sector Weight
1 Healthcare 22.84%
2 Industrials 19.01%
3 Technology 16.97%
4 Consumer Discretionary 11%
5 Communication Services 8.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PETQ
226
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$1.38M 0.05%
+58,643
New +$1.81M
USPH icon
227
US Physical Therapy
USPH
$1.22B
$1.37M 0.05%
13,389
+1,396
+12% +$155K
DSPG
228
DELISTED
DSP Group Inc
DSPG
$1.36M 0.05%
121,169
+31,740
+35% +$371K
CORE
229
DELISTED
Core Mark Holding Co., Inc.
CORE
$1.34M 0.05%
57,870
+5,486
+10% +$167K
ANIP icon
230
ANI Pharmaceuticals
ANIP
$1.78B
$1.31M 0.05%
29,139
+2,947
+11% +$154K
SYY icon
231
Sysco
SYY
$40.3B
$1.3M 0.05%
20,785
SRDX
232
DELISTED
Surmodics
SRDX
$1.29M 0.05%
27,314
+3,121
+13% +$187K
NSSC icon
233
Napco Security Technologies
NSSC
$1.48B
$1.29M 0.05%
163,712
+14,018
+9% +$107K
EXPE icon
234
Expedia Group
EXPE
$37.3B
$1.26M 0.05%
11,161
+2,668
+31% +$319K
RLGT icon
235
Radiant Logistics
RLGT
$395M
$1.25M 0.05%
294,245
+164,235
+126% +$864K
CNC icon
236
Centene
CNC
$32.5B
$1.24M 0.05%
21,580
-382
-2% -$25.6K
IWM icon
237
iShares Russell 2000 ETF
IWM
$81.9B
$1.23M 0.04%
9,204
+4,919
+115% +$734K
CSLT
238
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$1.22M 0.04%
560,282
+268,098
+92% +$665K
PLUS icon
239
ePlus
PLUS
$2.34B
$1.21M 0.04%
33,992
+3,462
+11% +$140K
TITN icon
240
Titan Machinery
TITN
$445M
$1.21M 0.04%
91,836
+8,780
+11% +$131K
DXPE icon
241
DXP Enterprises
DXPE
$2.98B
$1.2M 0.04%
42,967
+4,225
+11% +$150K
EZPW icon
242
Ezcorp Inc
EZPW
$1.71B
$1.1M 0.04%
+141,772
New +$1.34M
ZUMZ icon
243
Zumiez
ZUMZ
$339M
$1.09M 0.04%
+57,092
New +$1.21M
CLB icon
244
Core Laboratories
CLB
$521M
$1.06M 0.04%
17,735
-1,024
-5% -$88.4K
WHD icon
245
Cactus
WHD
$5.44B
$1.02M 0.04%
+37,397
New +$1.22M
VNDA icon
246
Vanda Pharmaceuticals
VNDA
$302M
$1M 0.04%
38,264
+13,649
+55% +$321K
IWC icon
247
iShares Micro-Cap ETF
IWC
$1.5B
$990K 0.04%
12,002
+8,399
+233% +$780K
NVDA icon
248
NVIDIA
NVDA
$5.42T
$920K 0.03%
275,640
-3,640
-1% -$17.4K
EGRX
249
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$912K 0.03%
22,628
+2,101
+10% +$108K
PGTI
250
DELISTED
PGT, Inc.
PGTI
$882K 0.03%
55,618
+14,175
+34% +$274K

Similar funds

Rice Hall James & Associates's Q4 2018 Portfolio in Review

As of Q4 2018, Rice Hall James & Associates held 327 positions worth $2.74B, down 1.9% from $2.79B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Rice Hall James & Associates deployed $616M of net new capital in Q4 2018, opening 27 new positions and adding to 203 existing holdings. Its largest new stake was Myriad Genetics: 800,553 shares worth $23.3M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Coherent, an estimated $12.2M trimmed.

  • Rice Hall James & Associates's largest Q4 2018 buy was Myriad Genetics: 800,553 shares worth $23.3M.
  • Rice Hall James & Associates added most to WW International in Q4 2018, an estimated $26.6M increase.
  • Rice Hall James & Associates's biggest Q4 2018 reduction was Coherent, cutting an estimated $12.2M.
  • Rice Hall James & Associates fully exited Conduent in Q4 2018, selling an estimated $25.1M.
  • Rice Hall James & Associates's ten largest holdings make up 21% of its $2.74B portfolio in Q4 2018.
  • Rice Hall James & Associates opened 27 new positions and closed 34 in Q4 2018.
  • Rice Hall James & Associates's portfolio value fell 1.9% quarter-over-quarter to $2.74B.

Based on Rice Hall James & Associates's 13F filing for Q4 2018, filed 14 Feb 2019.